Anti-PrP antibodies detected at terminal stage of prion-affected mouse

Cellular Immunology

Volumn 263, Issue 2, 2010, Pages 212-218

  Sassa, Yukiko ^a   Kataoka, Natsumi ^b   Inoshima, Yasuo ^a   Ishiguro, Naotaka ^a  

^a GIFU UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Anti PrP antibody; Immune response; Prion

Indexed keywords

EPITOPE; PRION PROTEIN ANTIBODY; RECOMBINANT ANTIBODY; RECOMBINANT PRION PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BRAIN HOMOGENATE; CELL DIVISION; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXPERIMENTAL MOUSE; FEMALE; IMMUNE SYSTEM; IMMUNIZATION; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; TERMINAL DISEASE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PRIONS; PROGNOSIS; PRPSC PROTEINS; RECOMBINANT FUSION PROTEINS; SCRAPIE;

ANIMALIA; MUS;

EID: 77953359996     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.03.018     Document Type: Article

References (31)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA 1998, 95:13363-13383.
2. Caughey B., Raymond G.J. The scrapie-associated form of PrP is made form a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 1991, 266:18217-18223.
3. Gardiner A.C. Gel diffusion reactions of tissues and sera from scrapie-affected animals. Res. Vet. Sci. 1966, 7:190-195.
4. Clarke M.C., Haig D.A. Attempts to demonstrate neutralizing antibodies in the sera of scrapie-affected animals. Vet. Rec. 1966, 78:647-649.
5. Brown P., Hooks J., Roos R., Gajdusek D.C., Gibbs C.J. Attempt to identify the agent for Creutzfeldt-Jakob disease by CF antibody relationship to known viruses. Nat. New Biol. 1972, 235:149-152.
6. Marsh R.F., Pan I.C., Hanson R.P. Failure to demonstrate specific antibody in transmissible mink encephalopathy. Infect. Immun. 1970, 2:727-730.
7. Porter D.D., Porter H.G., Cox N.A. Failure to demonstrate a humoral immune response to scrapie infection in mice. J. Immunol. 1973, 111:1407-1410.
8. Curin Serbec V., Bresjanac M., Popvic M., Pretnar Hartman K., Galvani V., Rupreht R., Cernilec M., Vranac T., Hafner I., Jerala R. Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue. J. Biol. Chem. 2004, 279:3694-3698.
9. Collis S.C., Kimberlin R.H., Millson G.C. Immunoglobulin G concentrations in the sera of Herdwick sheep with natural scrapie. J. Comp. Pathol. 1979, 89:389-396.
10. Betmouni S., Perry V.H., Gordon J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 1996, 74:1-5.
11. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 1987, 61:3688-3693.
12. Rubenstein R., Kascsak R.J., Papini M., Kascsak R., Carp R.I., LaFauci G., Meloen R., Langeveld J. Immune surveillance and antigen conformation determines humoral immune response to the prion protein immunogen. J. Neurovirol. 1999, 5:401-413.
13. Souan L., Tal Y., Felling Y., Cohen I.R., Taraboulos A., Mor F. Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur. J. Immunol. 2001, 31:2338-2346.
14. Sigurdsson E.M., Brown E.R., Daniels M., Kascsak R.J., Kascsak R., Carp R., Meeker H.C., Frangione B., Wisniewski T. Immunization delays the onset of prion disease in mice. Am. J. Pathol. 2002, 161:13-17.
15. Schwarz A., Kratke O., Burwinkel M., Riemer C., Schultz J., Henklein P., Bamme T., Baier M. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci. Lett. 2003, 350:187-189.
16. White A.R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., Anstee D., Collinge J., Hawke S. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003, 422:80-83.
17. Bolton D.C., Bendheim P.E., Marmorstein A.D., Potempska A. Isolation and structural studies of the intact scrapie agent protein. Arch. Biochem. Biophys. 1987, 258:579-590.
18. Shinagawa M., Takahashi K., Sasaki S., Doi S., Goto H., Sato G. Characterization of scrapie agent isolated from sheep in Japan. Microbiol. Immunol. 1985, 29:543-551.
19. Kim C.L., Umetani A., Matsui T., Ishiguro N., Shinagawa M., Horiuchi M. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 2004, 320:40-51.
20. Dikinson A.G., Meikle V.M. A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genet. Res. 1969, 13:213-215.
21. C by anti-PrP antibody prevents protease-resistant PrP formation. J. Gen. Virol. 2004, 85:3473-3482.
22. Paramithiotis E., Pinard M., Lawton T. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 2003, 9:893-899.
23. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001, 412:739-743.
24. Sc in spleens of some scrapie-infected sheep but not BSE-infected cows. J. Gen. Virol. 1997, 78:2389-2396.
25. Klein M.A., Frigg R., Flechisig E., Raeber A.J., Kalinke U., Bluethmann H., Bootz F., Suter M., Zinkernagel R.M., Aguzzi A. A crucial role for B cells in neuroinvasive scrapie. Nature 1997, 390:687-690.
26. Montrasio F., Frigg R., Glatzel M., Klein M.A., Mackay F., Aguzzi A., Weissmann C. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 2000, 288:1257-1259.
27. Heppner F.L., Aguzzi A. Recent developments in prion immunotherapy. Curr. Opin. Immunol. 2004, 16:594-598.
28. Song C.H., Furuoka H., Kim C.L., Ogino M., Suzuki A., Hasebe R., Horiuchi M. Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice. J. Gen. Virol. 2008, 89:1533-1544.
29. Polymenidou M., Heppner F.L., Pellicioli E.C., Urich E., Miele G., Wopfner F., Schaetzl H.M., Becher B., Aguzzi A. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl. Acad. Sci. USA 2004, 101:14670-14676.
30. Tal Y., Souan L., Cohen I.R., Meiner A., Taraboulos A., Mor F. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice. J. Neurosci. Res. 2003, 71:286-290.
31. Bade S., Baier M., Boetel T., Frey A. Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy. Vaccine 2006, 24:1242-1253.